MRFR offers a Phenomenal Analysis of Global Nuclear Medicine Market by Segmentation, Regional Analysis, Top Companies, Scope, and Applications. Covering North America, Europe, Asia Pacific, Middle East and Africa. And It Is Incorporated On Marketresearchfuture.Com With 100 Pages.
Nuclear Medicine Market – Overview
The research study studies all the variables affecting the nuclear medicine market’s growth in order to present a comprehensive look into the market’s present condition and possible growth trajectory over the forecast period from 2018 to 2023.
Nuclear medicine has become an important part of the healthcare sector in recent years due to the steady development of better, more technologically advanced variants of nuclear medicine, as well as the rising prevalence of target conditions such as cancer and cardiovascular diseases. Cancer is one of the deadliest diseases in the modern world and is only expected to rise in prevalence over the forecast period. Along with AIDS, cancer remains one of the last major diseases with which humans have not been able to deal satisfactorily. Despite developments in recent decades, cancer remains a major killer around the world. The nuclear medicine market is thus set to benefit from the dire conditions regarding the prevalence and deadliness of cancer around the world over the forecast period.
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/6674
The increasing use of nuclear medicine for diagnostics is also likely to be a major demand channel for the global nuclear medicine market over the forecast period. The massive development of diagnostics channels has been one of the major factors of the healthcare sector’s growth and evolution over the last decade and more, with accurate and early diagnostics taking on an ever more important role in the face of the realization of the importance of early diagnosis in treating any condition well. The benefits provided by nuclear diagnostic methods are likely to drive the demand from the nuclear medicine market over the forecast period.
Key players in the global nuclear medicine market include Bayer, Curium, Nordion Inc., Mallinckrodt Pharmaceuticals, Medtronic plc, Jubilant Lifesciences, Advanced Accelerators Applications, Lantheus Medical Imaging, Bracco Imaging, GE Healthcare, and Cardinal Health.
Curium signed an agreement in 2018 to acquire Cyclopharma’s operations in France, including manufacturing and commercial operations. France could emerge as a strong regional market for nuclear medicine over the forecast period due to the support for nuclear technology in the country and the resultant development of a widespread research infrastructure for research into applications of the same.
The report segments the global nuclear medicine market by product type, application, end use, and region.
By product type, the nuclear medicine market is segmented into diagnostic nuclear medicine and therapeutic radiopharmaceuticals. The former is further segmented into SPECT radiopharmaceuticals and PET radiopharmaceuticals, while the latter is divided into alpha emitters, beta emitters, and brachytherapy isotopes.
By application, the global nuclear medicine market is segmented into diagnostic applications and therapeutics applications. The former is segmented into SPECT and PET, while the latter is segmented into thyroid, bone metastasis, endocrine tumors, lymphoma, and others.
By end use, the nuclear medicine market is segmented into hospitals and diagnostic centers, research institutes, and others.
The global nuclear medicine market is segmented by geography into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is likely to be the major contributor to the global nuclear medicine market over the forecast period thanks to the dominant contribution of North American countries such as the U.S. and Canada. The medical research scenario in the U.S. is highly advanced and developed enough to incorporate advancements in the field of nuclear medicine into its stride easily. The supportive U.S. laws have provided the perfect environment for the nuclear medicine market to grow and proliferate. The increasing threat of cancer in the U.S. has made cancer research a prime topic for healthcare giants, leading to nuclear medicine taking on an important role. This is likely to remain a key driver for the nuclear medicine market in North America over the forecast period.
Browse Complete 125 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/nuclear-medicine-market-6674
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312